Exome Asset Management LLC — COGENT BIOSCIENCES INC COGT: Quarterly 13F Position History
Exome Asset Management LLC has reported COGENT BIOSCIENCES INC (COGT) on 5 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2025. As of Q1 2026, the position is sized at 278,533 shares ($10.7M market value, 6.31% of the equity book). Quarter-over-quarter share count change: 27,035 (-8.8%) .
- 278,533Shares Held (Latest Filing)
- $10.7MReported Market Value (Latest Filing)
- 6.31%Portfolio Weight (% of 13F Equity Book)
- 27,035Quarter-over-Quarter Share Change
- -$133.0KQuarter-over-Quarter Value Change
- 621,678Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 278,533 | 27,035 | -8.8% | $10.7M | 6.31% | $38.49 |
| Q4 2025 | 305,568 | 137,979 | -31.1% | $10.9M | 5.36% | $35.52 |
| Q3 2025 | 443,547 | 90,100 | -16.9% | $6.4M | 4.21% | $14.36 |
| Q2 2025 | 533,647 | 88,031 | -14.2% | $3.8M | 3.15% | $7.18 |
| Q1 2025 | 621,678 | — | — | $3.7M | 3.34% | $5.99 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Exome Asset Management LLC first disclose a COGT position in 13F-HR filings?
Exome Asset Management LLC first reported COGENT BIOSCIENCES INC (COGT) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was Exome Asset Management LLC's most recent quarter-over-quarter share-count change in COGT?
Between Q4 2025 and Q1 2026, Exome Asset Management LLC reduced its COGT position by 27,035 shares (-8.8%), leaving 278,533 shares at a market value of $10.7M.
Does the implied price-per-share represent Exome Asset Management LLC's cost basis in COGT?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.